
    
      A total of 117 women affected by bacterial vaginosis or vaginitis with concomitant HPV
      infections were enrolled at Department of Gynecological Obstetrics and Urological Sciences,
      La Sapienza University, Rome, Italy between February 2015 and March 2016. Women were
      randomized in two groups, standard treatment (metronidazole 500 mg twice a day for 7 days or
      fluconazole 150 mg orally once a day for 2 consecutive days) plus short-term (3 months)
      vaginal Lactobacillus implementation (group 1, short probiotics treatment protocol group,
      n=60) versus the same standard treatment plus long-lasting (6 months) vaginal Lactobacillus
      rhamnosus BMX 54 administration (group 2, treatment group, n=57).
    
  